Dropout: Rethinking Pharma's Next Growth Lever with Mohamed El-Zayat

Beyond the Pill – the AI and architecture of the future.

The future of healthcare won’t be won in the lab alone — it will be won at the patient’s side. Beyond the Pill, hosted by Grace McNamara, goes inside the shift transforming pharma and digital health: how companies move past the product to deliver real outcomes through adherence, patient engagement, and technology that meets people where they already are. Each episode brings on the leaders making it happen — pharma executives, clinicians, founders, and changemakers — for candid conversations on market access, AI in the clinic, emerging-market growth, and the human side of digital transformation. Practical, forward-looking, and grounded in what actually works, Beyond the Pill is for anyone building the next era of patient care. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

Scaling the Doctor: Inside Elfie’s First Government MOU for AI-Powered Care

What does it take for a government to put its name behind an AI health platform? In this episode of Elfie Voices: Rethinking Health, Grace McNamara sits down with Elfie co-founders Ofir and JF to unpack a landmark moment: their first Memorandum of Understanding with a government to deploy ELFIECARE across doctors and hospitals — free of charge. After five years proving the hardest thing in digital health — patient engagement — Elfie’s data surfaced a defining insight: the doctor is the single biggest agent of change, with doctor-referred patients showing double the adherence and double the impact. That insight reshaped the company’s next move: empowering clinicians with conversational AI that plugs into existing workflows on WhatsApp, never replacing the systems already in place. Ofir and JF lay out the economics that make Ministries of Health pay attention — exploding chronic-disease costs, the urgent need to “scale the doctor,” and a model that delivers controlled, compliant AI with local data residency in markets the big cloud providers don’t even serve. They explain why Elfie’s moat is the difficult path most vendors avoid: free deployment, ministry authorization, demonstrated medical impact, and a real-time epidemiologic data layer that finally lets governments and pharma see whether their spending actually works. For leaders in government and pharma, this is a candid look at how to align short-term incentives toward long-term population health — and how rigorous AI governance Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

The Unexpected Cost of Ignoring Venous Disease

Venous disease doesn’t have to be just a cosmetic concern—it's a hidden indicator of broader cardiovascular health that’s often overlooked. Why are we failing to measure and prioritize venous health at the system level—and what’s at stake if we don’t change? In this eye-opening episode, Dr. Vito Ademe, an interventional vascular cardiologist and passionate phlebologist, reveals how under-measurement and under-recording of venous disease leave millions at risk of costly, preventable complications. You’ll discover how venous disease is more prevalent than many realize and how it silently contributes to heart failure, strokes, and systemic inflammation. Dr. Vito breaks down the critical link between venous health and cardiovascular risk, emphasizing the importance of systemic measurement and early detection. Learn about groundbreaking concepts like “wellness phlebology,” where understanding the root causes of venous issues can prevent systemic health decline long before crises occur. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

Dropout: Rethinking Pharma's Next Growth Lever with Mohamed El-Zayat

What if the biggest threat to your blockbuster isn't a competing molecule — but the patient who quietly stops refilling after month two? In this episode, Grace McNamara sits down with Mohamed El-Zayat, Elfie's new Country Manager for Egypt and the Middle East and a 22-year pharma veteran (Pfizer, AstraZeneca, Merck) across marketing, global brand leadership, and patient access. Mohamed breaks down the three hidden competitors every chronic-disease brand faces — therapy dropout, the shrinking HCP-patient consult, and the post-prescription data blackout — and explains why a connected patient ecosystem, not another standalone app, is the strategic unlock. Inside the conversation: * Why adherence, not rival brands, is the real battleground in chronic care * How Elfie Care is positioned to be "the most significant launch in healthcare in the next 10 years" * Why longitudinal, patient-reported + wearable + lab data is pharma's next real-world evidence goldmine * The economics of replacing 65 fragmented PSP apps with one ecosystem spanning pharma, payers, ministries, HCPs, and pharmacies * What insurers, ministries of health, and brand teams should be asking now A sharp, strategic listen for pharma executives, patient access leaders, RWE teams, and payer innovators. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

Are We Undervaluing The Power Of Nutrition?

Most health systems overlook one of the most impactful, cost-effective tools in chronic disease: food. What if nutrition was not just lifestyle advice, but a direct, measurable clinical intervention? In this episode of Elfie Voices, Aya speaks with Débora Gapanowicz, a dietitian specialising in diabetes and functional nutrition, about rethinking the role of food in population health. Débora explains how everyday dietary choices can shape cardiometabolic biomarkers in real time, from blood glucose to blood pressure, highlighting nutrition as a powerful but often underused part of care. The conversation explores why nutrition has historically sat outside clinical practice, how digital platforms like Elfie are helping make it more measurable, and what the economic case looks like for integrating it more formally into healthcare systems. A thoughtful shift in perspective, with real implications for prevention, cost, and long-term outcomes. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]